Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Metahelix Life Sciences is a premier Indian agricultural biotechnology company specializing in the research, development, and commercialization of hybrid seeds. Established in 2001 by a team of experienced scientists, the company focuses on enhancing crop productivity through advanced molecular breeding and transgenic technologies. Its product portfolio, marketed under the 'Dhaanya' brand, includes high-yielding hybrids for field crops such as maize, rice, cotton, and pearl millet. Metahelix was acquired by Rallis India, a Tata Group company, in 2010 to strengthen its presence in the seeds and agri-inputs market. In 2019, the company was formally merged into Rallis India to streamline operations and leverage synergies within the Tata agricultural ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Metahelix Life Sciences.